Project - Minnesota MDMA analogue treatments need help!

[EarthBounded]

Point blank there are young adults locked up in psychiatric wards in my region that are not getting adequate treatment please read:

This is for anyone who has true molecular Knowledge of Mainly MDMA analogues. Considering 85% of the " Molly " On our streets is Methylone / BZP related this study will focus on RC's.

If you are part of the EDM scene you already know why we need help, BK-MDMA is tackling our streets. Despite pure greed, robberies and lack of information we have a larger problem.

Clinical psychiatrist's lack the proper information in treating someone coming down from an MDMA or Analogue addiction, This is not for users or dealers, if you are one of the two do not post or IM me, I understand your lifestyle, but imagine cleaning it up for the general population.

I have a few Bio-Chemist's and Psychiatrists I am in contact with, I want to construct guidelines and treatments to be distributed in the midwest, With information on recovery, here are a few examples on what a psychiatrist who had just sent a patient to the mental ward did not know were possible treatments / preventive measure's in serotonin syndrome and depletion, ( this is just what I have seen, which is more than enough ):

Alpha Lipolic Acid
5-HTP
Healthy diet and exercise

If anyone want's to help me out PM me or post useful information on HR with Phenethylamine & Cathinone class drugs. For pretty immediate results.

I am willing to meet anyone locally, I will not speak about blackmarket information, use, experience, sourcing, nothing this is for science and for those who are being punished by misinformation.

I hate to be blunt but this is targeted towards an elderly generation of psychiatrist who practice privately and are completely oblivious, it is not there fault, however I am here for there patients.

Thanks

EB

 

[EarthBounded]

Bump-

If you are in the midwest and fit the bill PM me.

Mods sorry bout the bump this is serious.

Please change Minnesota to midwest.

 

[lovepsychadelics]

Serotonin syndrome is usually monitored in a clinical setting (ie medical ward in hospital not psychiatric unit) until the crisis is resolved and the patient medically stable. This is no different to an OD of SSRI drug. SRA or SSRA substances that cause serotonin syndrome are resolved in the same fashion as an SSRI drug OD and are also treated as an intentional overdose. This means the individual who has taken an excessive dose of say bk-MDMA or similar will be placed into psychiatric care on an involuntary treatment order after the treating neurologist has declared them medically fit. This applies to my country of origin.

Benzo's (yes we Ozzie's are fond of shortening almost every word in the English language) are used to treat insomnia, tachycardia etc. Basically treatment for severe symptoms that are present with appropriate medical interventions at least in the initial crisis is past and then off to the psychiatric inpatient setting. I think there is enough data available that these elderly psychiatrist can familiarize themselves with in terms of clinical journal publications etc. As far as I understand it the mode of action is the important part of the drug's pharmacodynamic's that need's to be understood. The question should be what neurotransmitters are effected by the substance, how is it effected, how many receptor types are effected and to what extent as serotonin is often just one of these. From this data it can be hypothesized that current treatment for overdose with pharmaceutical substances with similar neurotransmitter activity as the illicit counterpart may be a good reference point.

As an example take 6-APB it is a serotonin releasing agent and to a lesser extent effects dopamine and noradrenaline receptors as well. There is speculation that it may also have mild MAOI activity but this is currently unproven as far as I am aware. A good start would be for the biochemists to have a look at the work of Dr David E. Nicholes who developed 6-APB in the 90's. As for bk-MDMA I believe it was developed by Jacob Peyton and Alexander Shulgin in 1996 for potential use as an antidepressant.

Hope this is of some value. We have a clinical competency scheme in this country that requires all medical and allied health professionals to do a minimum equivalent study in their field of expertise to equate to 20 hours in contemporary development in the area of practice. Hope this is of some help. If your after molecular knowledge it's already freely available and published by the original development teams. I ask you: how else did the Chinese RC manufactures come up with the drugs in the first place?